228 related articles for article (PubMed ID: 10675354)
21. Peroxisomal proliferator-activated receptor alpha deficiency diminishes insulin-responsiveness of gluconeogenic/glycolytic/pentose gene expression and substrate cycle flux.
Xu J; Chang V; Joseph SB; Trujillo C; Bassilian S; Saad MF; Lee WN; Kurland IJ
Endocrinology; 2004 Mar; 145(3):1087-95. PubMed ID: 14670991
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic Characterization of Mice Carrying Homozygous Deletion of KLF11, a Gene in Which Mutations Cause Human Neonatal and MODY VII Diabetes.
Mathison A; Escande C; Calvo E; Seo S; White T; Salmonson A; Faubion WA; Buttar N; Iovanna J; Lomberk G; Chini EN; Urrutia R
Endocrinology; 2015 Oct; 156(10):3581-95. PubMed ID: 26248217
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.
Bergeron R; Yao J; Woods JW; Zycband EI; Liu C; Li Z; Adams A; Berger JP; Zhang BB; Moller DE; Doebber TW
Endocrinology; 2006 Sep; 147(9):4252-62. PubMed ID: 16728496
[TBL] [Abstract][Full Text] [Related]
24. Rapid induction of peroxisome proliferator-activated receptor gamma expression in human monocytes by monosodium urate monohydrate crystals.
Akahoshi T; Namai R; Murakami Y; Watanabe M; Matsui T; Nishimura A; Kitasato H; Kameya T; Kondo H
Arthritis Rheum; 2003 Jan; 48(1):231-9. PubMed ID: 12528124
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.
Sugden MC; Bulmer K; Gibbons GF; Knight BL; Holness MJ
Biochem J; 2002 Jun; 364(Pt 2):361-8. PubMed ID: 12023878
[TBL] [Abstract][Full Text] [Related]
26. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.
Ma LJ; Marcantoni C; Linton MF; Fazio S; Fogo AB
Kidney Int; 2001 May; 59(5):1899-910. PubMed ID: 11318962
[TBL] [Abstract][Full Text] [Related]
28. An adipose tissue-independent insulin-sensitizing action of telmisartan: a study in lipodystrophic mice.
Rong X; Li Y; Ebihara K; Zhao M; Aini W; Kusakabe T; Hirata M; Miyamoto L; Murray M; Nakao K
J Pharmacol Exp Ther; 2009 Dec; 331(3):1096-103. PubMed ID: 19770292
[TBL] [Abstract][Full Text] [Related]
29. [Association of Pro12Ala mutation in peroxisome proliferator-activated receptor gamma 2 with obesity and diabetes in Chinese population].
Wang C; Zhai F; Chi Y; Wang G
Wei Sheng Yan Jiu; 2004 May; 33(3):317-20. PubMed ID: 15211802
[TBL] [Abstract][Full Text] [Related]
30. Reduction of phosphodiesterase 3B gene expression in peroxisome proliferator-activated receptor gamma (+/-) mice independent of adipocyte size.
Ogura T; Osawa H; Tang Y; Onuma H; Ochi M; Nishimiya T; Kubota N; Terauchi Y; Kadowaki T; Makino H
FEBS Lett; 2003 May; 542(1-3):65-8. PubMed ID: 12729899
[TBL] [Abstract][Full Text] [Related]
31. The effect of high glucose and PPAR-gamma agonists on PPAR-gamma expression and function in HK-2 cells.
Panchapakesan U; Pollock CA; Chen XM
Am J Physiol Renal Physiol; 2004 Sep; 287(3):F528-34. PubMed ID: 15113752
[TBL] [Abstract][Full Text] [Related]
32. PPAR gamma and the treatment of insulin resistance.
Olefsky JM; Saltiel AR
Trends Endocrinol Metab; 2000 Nov; 11(9):362-8. PubMed ID: 11042466
[TBL] [Abstract][Full Text] [Related]
33. The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity.
Celi FS; Shuldiner AR
Curr Diab Rep; 2002 Apr; 2(2):179-85. PubMed ID: 12643137
[TBL] [Abstract][Full Text] [Related]
34. The PPARgamma2 polymorphism pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients.
Jacob S; Stumvoll M; Becker R; Koch M; Nielsen M; Löblein K; Maerker E; Volk A; Renn W; Balletshofer B; Machicao F; Rett K; Häring HU
Horm Metab Res; 2000 Oct; 32(10):413-6. PubMed ID: 11069206
[TBL] [Abstract][Full Text] [Related]
35. The lignan-rich fractions of Fructus Schisandrae improve insulin sensitivity via the PPAR-γ pathways in in vitro and in vivo studies.
Kwon DY; Kim DS; Yang HJ; Park S
J Ethnopharmacol; 2011 May; 135(2):455-62. PubMed ID: 21440615
[TBL] [Abstract][Full Text] [Related]
36. Farnesoid X receptor is essential for normal glucose homeostasis.
Ma K; Saha PK; Chan L; Moore DD
J Clin Invest; 2006 Apr; 116(4):1102-9. PubMed ID: 16557297
[TBL] [Abstract][Full Text] [Related]
37. Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice.
Bernal-Mizrachi C; Weng S; Feng C; Finck BN; Knutsen RH; Leone TC; Coleman T; Mecham RP; Kelly DP; Semenkovich CF
Nat Med; 2003 Aug; 9(8):1069-75. PubMed ID: 12847522
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the relationship between PPAR-gamma 2 gene variants and severe insulin resistance in obese patients with impaired glucose tolerance.
Blüher M; Paschke R
Exp Clin Endocrinol Diabetes; 2003 Apr; 111(2):85-90. PubMed ID: 12746759
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptor-gamma and insulin action: insights from human genetics.
Chatterjee VK
Horm Res; 2003; 60 Suppl 3():51-5. PubMed ID: 14671397
[TBL] [Abstract][Full Text] [Related]
40. Inconsistent effects of the proline12 --> alanine variant of the peroxisome proliferator-activated receptor-gamma2 gene on body mass index in children and adolescent girls.
Witchel SF; White C; Siegel ME; Aston CE
Fertil Steril; 2001 Oct; 76(4):741-7. PubMed ID: 11591408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
